HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Making Offer For J-Beauty Firm Ci:z Amid Throes Of Consumer Biz Revival

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson intends to buy out Japan-based Ci:z Holdings for north of $2bn, which would give it full ownership of the firm’s dermocosmetic brand portfolio, including Dr.Ci:Labo, a standout performer for J&J’s beauty and larger consumer business in 2018.

You may also be interested in...



J&J's Baby, Beauty Sectors Boost Consumer Health Sales Rebound

Johnson’s baby product sales picked up in the third quarter after a rough start as its baby care division sales up 20% in the US to $120m. US consumer health sales grew 6.6% to $1.37bn, also helped by total worldwide beauty sales increasing 6.5% to $1.08bn.

J&J Relaunches Johnson’s Baby Care As Greener, Gentler, With Fewer Ingredients

The overhaul in line with “modern parents’ preferences” could be what’s needed to rouse the sleepy brand and spur Consumer business growth.

CVS Joins Retailers Cramming Shelves With K-Beauty Favorites

CVS teamed with Peach & Lily founder Alicia Yoon to curate an assortment of offerings from South Korean skin-care brands and Yoon’s own Peach Slices line, rolling out to 2,100 doors nationwide in April. With Target, Ulta and Sephora also building their K-beauty offerings, mainstream players may face growing competition for shelf space as millennials gravitate to the quirky and fun, and away from science-driven anti-aging.

Topics

Related Companies

UsernamePublicRestriction

Register

RS122389

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel